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Experimental Zika Virus Infection in 
the Pregnant Common Marmoset 
Induces Spontaneous Fetal 
Loss and Neurodevelopmental 
Abnormalities
Maxim Seferovic1, Claudia Sánchez-San Martín2, Suzette D. Tardif3, Julienne Rutherford4, 
Eumenia C. C. Castro1, Tony Li2, Vida L. Hodara3,5, Laura M. Parodi3,5, Luis Giavedoni3,5,  
Donna Layne-Colon3, Manasi Tamhankar5, Shigeo Yagi6, Calla Martyn2, Kevin Reyes2,  
Melissa A. Suter1, Kjersti M. Aagaard1, Charles Y. Chiu  2,7 & Jean L. Patterson5
During its most recent outbreak across the Americas, Zika virus (ZIKV) was surprisingly shown to cause 
fetal loss and congenital malformations in acutely and chronically infected pregnant women. However, 
understanding the underlying pathogenesis of ZIKV congenital disease has been hampered by a lack 
of relevant in vivo experimental models. Here we present a candidate New World monkey model of 
ZIKV infection in pregnant marmosets that faithfully recapitulates human disease. ZIKV inoculation at 
the human-equivalent of early gestation caused an asymptomatic seroconversion, induction of type 
I/II interferon-associated genes and proinflammatory cytokines, and persistent viremia and viruria. 
Spontaneous pregnancy loss was observed 16–18 days post-infection, with extensive active placental 
viral replication and fetal neurocellular disorganization similar to that seen in humans. These findings 
underscore the key role of the placenta as a conduit for fetal infection, and demonstrate the utility of 
marmosets as a highly relevant model for studying congenital ZIKV disease and pregnancy loss.
Zika virus (ZIKV) is a mosquito-borne (Aedes genus) arbovirus of the Flaviviridae family. Originally discovered 
in Uganda in 19471, previous outbreaks of ZIKV were largely sporadic across Southeast Asia and the equato-
rial African belts, but later spread east resulting in an outbreak in Yap Island in 2007, followed by epidemics in 
French Polynesia, New Caledonia, the Cook Islands, and Easter Island in 2013 and 20141,2. The virus emerged in 
the Caribbean and South America in late 2014, persisting currently across the Western Hemisphere as of 2017 
(https://www.cdc.gov/zika/geo/index.html). The virus is geographically spread as a result of human travel from 
endemic regions, alongside human-to-human transmission via sexual intercourse, with blood transfusions, and 
via vertical maternal-fetal transmission2–5.
In contrast to other flaviviruses, ZIKV causes fetal loss and malformations which serve as the phenotypic basis 
for human congenital Zika syndrome (CZS)6–9. Although no other flavivirus is known to cause disseminated 
fetal neural malformations in humans, worldwide concern for latent viral disease was raised following several 
case reports demonstrating persistent ZIKV RNA in the amniotic fluid, placenta, and fetal neural tissue weeks to 
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months after initial maternal infection3,4. While 80% of human infections remain asymptomatic, a minority of 
patients experience a self-resolving acute illness characterized by fever, rash, and/or conjunctivitis5. ZIKV has also 
been associated with acute neurological illnesses in children and adults, including meningoencephalitis and acute 
flaccid paralysis, as well as Guillain-Barré syndrome10.
A number of animal models of ZIKV infection have been described to date. These include several murine 
models in which ZIKV-associated complications in pregnant females required the use of immunodeficient ani-
mals with defects in the interferon-related signaling pathways6–8,11. Rhesus, pigtail, and cynomolgus macaque 
and squirrel monkey models of ZIKV infection have also been developed9,12–16. Acute ZIKV infection in these 
nonhuman primate (NHP) models early in the course of the pregnancy have been shown to result in an average 
spontaneous abortion rate of 38% (Dudley et al., under review), with one study in a single pigtailed macaque 
demonstrating impaired neurodevelopment associated with ZIKV infection of the fetal brain and neuroprogeni-
tor cells9. However, there are several limitations to existing NHP models of viral congenital infections, including 
long lengths of gestation, limited mating periods associated with long intervals of lactation-induced or seasonal 
ovulatory suppression between pregnancies, and a large body size that makes higher biocontainment housing and 
testing of limited-quantity vaccines or therapeutics challenging.
In contrast, mounting evidence over the past decade has pointed to the common marmoset (Callithrix jac-
chus), a rat-sized, neotropical primate, as a relevant and convenient model for investigating viral pathogenesis17. 
The common marmoset model has been shown to reproduce the human illnesses caused by Lassa virus18, Ebola/
Marburg virus19, and flavivirus (dengue virus and West Nile virus)20,21 infection. We also recently reported that 
the course of infection in ZIKV-infected male marmosets resembles that seen in acutely infected humans in 
many aspects22. Specifically, viral illness was subclinical, the virus persisted in body fluids such as semen and 
saliva for longer periods of time than in serum, and there were neutralizing antibody as well as characteris-
tic interferon-associated host responses. Encouraged by these initial studies demonstrating that viral illness in 
male marmosets is akin to the human condition, we sought to determine whether infection of marmoset dams 
would more faithfully recapitulate maternal infection and CZS in humans when compared to murine models 
and provide key opportunities not afforded by other NHP models. As a nonhuman primate, the marmoset has 
a hemomonochorial placental architecture that develops early in pregnancy23, a situation much more similar to 
humans than that of the chorioallantoic placental architecture of the mouse that is only mature relatively late in 
gestation24. Moreover, we hypothesized that crucial mechanistic insights pertaining to placental infection and 
vertical transmission could be reached as a result of the unusual but well described characteristics of trophoblast 
and embryonic development in the common marmoset. Marmosets have a delayed period of embryogenesis rel-
ative to humans23, resulting in the marmoset undergoing critical stages of neural development in association with 
a relatively far more mature placenta (both structurally and in terms of duration of the placenta as a functioning 
organ). Here we report the outcomes of experimental infection with ZIKV in two pregnant marmoset dams, and 
the resultant impact on the placenta and developing fetus.
Results
Experimental ZIKV infection of pregnant marmosets. We inoculated 2 pregnant marmosets (dams) 
with Brazil ZIKV strain SPH2015 (an Asian lineage strain first isolated in 2015) at estimated gestational days 79 
(Dam 1) and 68 (dam 2) with a dose at 2.5 × 105 plaque-forming units (PFU), followed by a second inoculation 
with the same dose 4 days later (Fig. 1). Gestational age prior to inoculation was confirmed by fetal sonogram 
with biometry and crown-rump length (CRL) measurements. The chosen gestational windows span the ongoing 
and prolonged periods of placentation in marmosets, as well as critical phases of embryonic neurodevelopment 
(Carnegie embryonic stages 16–23; Fig. 2). Both animals were assessed daily for evidence of clinical signs of 
illness, and remained asymptomatic following inoculation until delivery. Spontaneous expulsion of intrauterine 
demised fetuses at days 16 and 18 post-inoculation occurred for dams 1 and 2, respectively (Fig. 1A). Fetuses 
(dichorionic, diamniotic twins for Dam 1, singleton for dam 2) were documented via ultrasonography to be alive 
2 and 4 days prior to fetal demise and expulsion, respectively.
Viral load and serological analyses. Serum, saliva, and urine samples were collected longitudinally at a 
priori-determined specific intervals, including a pre-infection sample taken 5 days before infection, and for up to 
30 days following inoculation (Fig. 1A). Viral RNA loads were measured in body fluids and tissues by quantitative 
reverse transcription polymerase chain reaction (qRT-PCR) testing (Fig. 1A). Detectable viral loads up to 3 weeks 
post-inoculation and seroconversion by plaque reduction neutralization testing (PRNT) confirmed both active 
viral replication and acquired adaptive immunity, respectively Specifically, ZIKV was detectable in the serum for 
at least 1 week following inoculation by qRT-PCR, with a day 2 peak viral load of ~105 copies/mL, while ZIKV 
levels in urine and saliva peaked at later time points (day 10 and day 7) and persisted for 2 and 3 weeks respec-
tively (Fig. 1B). Both marmosets were seronegative prior to infection (Ab titers <1:20) and seroconverted at 30 
days post-infection with positive titers of 1:2560 for Dam 1 and 1:640 for dam 2 (Fig. 1A).
Maternal necropsy at day 30 post-inoculation demonstrated absence of viral RNA in all tested body fluids, 
including blood, urine, and saliva. This corresponded to 12 and 10 days post-pregnancy loss for dams 1 and 2, 
respectively. However, ZIKV RNA was detected by nucleic acid testing (NAT) in maternal lymph node, ocular, 
and renal tissues, as well as in placental tissues and fetal brain/cranium and abdominal tissues (Fig. 1C,D).
Gross and histological features of placenta and aborted fetuses. Two days prior to fetal demise and 
expulsion, Dam 1 was confirmed by fetal sonogram to carry a live dichorionic, diamniotic twin gestation with 
normal amniotic fluid volumes and cardiac activity. The spontaneous demise and delivery of the twin fetuses and 
their placentae were discovered approximately 20–36 hours after expulsion (3 days post sonogram). Both of the 
aborted fetuses were friable and each had a measured biparietal diameter (BPD) that were 50% of the expected 
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values based on the ultrasounds performed 2 and 4 days earlier; however, this is most likely due to cranial collapse 
and dolicocephaly typical in fetal tissue after prolonged (>4–6 hours) demise. One twin fetus was immediately 
placed in formalin for the histological analyses, while the other fetus was dissected for RNA viral load testing 
(Fig. 1C). The placenta was mauled by the dam and unsuitable for histological analysis.
For dam 2, early gestational sonogram at 56 days, prior to ZIKV inoculation, revealed a singleton gestation, 
an indication of early intrauterine demise of one of the fetuses that occurs in approximately 10–15% of marmoset 
pregnancies22. Thus, although marmosets are obligate carriers of multi-fetal gestations due to a polygenic set of 
Figure 1. Study overview and results from viral load and antibody testing. (A) Timeline showing days of 
sample collection before and following ZIKV inoculation at day 0, including collection of placental and fetal 
samples at time of fetal demise and expulsion (16–18 days post-inoculation). Measured Ab titers at days 7 and 
30 post-inoculation for dam 1, and at days -5, 2, 7, and 30 post-inoculation for dam 2 are also given. (B) Viral 
loads in serially collected body fluids. (C) Flow chart describing analysis of placental and fetal samples. (D) 
Viral loads in maternal tissues at time of necropsy, and in fetal/placental tissues at time of fetal demise. The 
error bars shown for the fetal/placental viral loads are based on multiple tissue replicates. Abbreviations: gd, 
gestational day; wk, week.
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synonymous and non-synonymous substitutions25,26, in a number of instances they have been shown to carry 
singleton fetuses successfully to term27. After confirming a continuing developing viable singleton gestation, dam 
2 was infected with 2 ZIKV inoculums on days 68 and 72. A viable singleton gestation was confirmed on day 
82 and subsequently demised with fetal expulsion on day 86. The single expulsed fetus and its placenta were 
immediately recovered; the head was formalin-fixed for histology while the body was dissected for RNA viral 
load testing (Fig. 1C). Formalin-fixed paraffin-embedded (FFPE) sections of the placenta alongside positive and 
negative controls were assessed for the presence of ZIKV using 4G2 antibody against a flavivirus envelope pro-
tein (Fig. 3A,B). The villous parenchyma stained strongly positive for ZIKV protein by immunohistochemistry 
(Fig. 3B). In situ hybridization (ISH), targeting positive-strand ZIKV RNA and its corresponding negative-strand 
replicative intermediate, established the presence of viral genomic RNA and active replication within placental 
tissue, respectively (Fig. 4A,B). Positive signal for genomic ZIKV RNA strands was adjacent to the nucleus, con-
sistent with the establishment of flaviviral replication factories in the endoplasmic reticulum28. The ZIKV protein 
immuno-staining overlapped with the hybridization positive and negative strand signals, with comparatively 
much stronger signal from the stable viral genomic strand (+) compared to the replication (−) strand (Fig. 4B). 
Despite clear evidence of extensive placental infection by ZIKV, examination of histological sections stained with 
hematoxylin and eosin (H&E) revealed no leukocyte infiltration and inflammation in the placenta (Fig. 4C); this 
is consistent with absence of placental inflammation observed in human CZS29,30.
Having established that the placenta in dam 2 actively harbored and propagated ZIKV, we next examined the 
abdomen and thorax from the dam 1 fetus for evidence of infection using the ISH (+) and (−) strand probes, 
reserving the corresponding abdomen and thorax from the dam 2 fetus for viral load testing (Figs 1C and 5). 
H&E stained sections were used to identify the primitive organs and tissues of the developing fetus (Fig. 5A). The 
hepatic tissue of the animal appeared highly autolyzed, consistent with the prolonged 20–36 hour post-expulsion 
period, but other tissues and structures were well preserved, with bone or developing cartilage of vertebrae and 
Figure 2. Comparison of the relative pace of placental and embryonic development in humans and marmosets. 
The embryonic stages shown encompass those that occurred in the Zika-infected marmoset embryos and 
reflect critical neurodevelopmental stages. The human blastocyst implants on day 6 post-conception, while 
in the marmoset implantation occurs on day 12. Marmoset organogenesis is complete by approximately day 
8032,58, compared to day 56 (end of the 8th week) in humans, marking the shift from embryo to fetus. The 
first appearance of chorionic vessels in the human placenta occurs in week 359; the corresponding period of 
20–25 days is when vessels appear in the marmoset placenta32. Erythroblasts first appear in human chorionic 
vessels around day 23, i.e. early week 4, the equivalent to marmoset day 36. In this regard, the marmoset may 
be delayed, because erythroblasts inside chorionic vessels are not reported to occur until days 46–50. In the 
human, maternal blood supply is not fully established until week 12, but initial entry of maternal blood into 
the intervillous space occurs as early as mid-week 6. In the marmoset placenta, maternal blood is first apparent 
on day 45, equivalent to late week 5 in the human placenta. In New World monkeys such as marmosets, 
placental interdigitation is described as “trabecular” with cytoplasmic bridges instead of “villous” with finger-
like appendages. As this minor anatomical difference is not known to be functionally significant, for clarity of 
comparison the terms “villous” and “intervillous spaces” are used to describe the marmoset placenta.
www.nature.com/scientificreports/
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ribs, and surrounding muscle and primitive mesenchymal tissue apparent and readily identifiable (Fig. 5Ai). The 
fetal thorax and abdomen were diffusely positive for ZIKV hybridization of both + and − RNA strands, with the 
strongest signal in liver tissue (Fig. 5Bii); however, ZIKV-specific hybridization of either strand was not stronger 
than that measured in the placenta (Fig. 4B). Differentiated bone and cartilage did not hybridize with either 
positive or negative strand probes of ZIKV, whereas viral infection of the surrounding muscle and mesenchymal 
progenitor tissue was apparent (Fig. 5B,C) with evident active viral replication (- strand ISH, Fig. 5A–C,iii). As 
with placenta, there was no evidence of inflammation in the fetal tissues despite the apparent extensive infection 
(Figs 4C and 5).
Given that the most prominent malformations associated with CZS, including microcephaly, are ocular or 
neurologic31, close examination of fetal cranium and its contents from both dam 1 and dam 2 fetuses was made 
to characterize and anatomically localize cephalic viral infection and replication. The ophthalmic and cerebral 
regions of a frontally sectioned head of dam 2 fetus were examined (Fig. 6). ZIKV signal from both positive 
viral genomic and negative replication strands was present behind the eye in the muscle and surrounding tis-
sue (Fig. 6A, arrows). Among the strongest cephalic signal was from the perineurium region of an intra-orbital 
nerve, likely ophthalmic (Fig. 6B). Neuroprogenitor cells (NP) of the developing cortical plate were also highly 
infected and shown to be actively replicating ZIKV (Fig. 6C, arrows). Similarly, the optic nerve and anatomy of 
the eye was most clearly visualized from a sagittal H&E stained section in the fetus of dam 1 (Fig. 7A), with the 
strongest ZIKV-ISH signal in the fetal head occurring in ocular muscle (Fig. 7B) and with evidence of active viral 
replication (Fig. 7C). Although the ZIKV signal was weaker in the brain of the fetus from dam 1 relative to the 
fetus from dam 2, areas of infection and active ZIKV replication were clearly observed (Figs 6 and 7), with H&E 
sections showing regions of disorganization within the cortical neurons indicating a disruption in development 
and neuronal migration patterns of the cerebral cortex (Fig. 8).
ZIKV genome sequencing from fetus and placenta. ZIKV genome sequencing from tissues and body 
fluids, done in parallel from the original inoculum, was performed to identify mutations arising after infection. 
In the infected placenta and singleton aborted fetus from dam 2, a single consensus coding mutation (99.5% 
frequency) was identified in the matrix protein resulting in an amino acid change from phenylalanine to leucine 
(F252L) (Supplementary Table S1). In contrast, this mutation was present in the original ZIKV inoculum at a 
frequency of 0.3%. Given that this is comparable to the Illumina error rate of 0.1%32, we could not determine 
whether the mutation arose de novo or was an ultra-low frequency variant selected for during infection. Notably, 
this identical mutation had been previously reported in a ZIKV genome sequenced from a human fetus with 
microcephaly33, despite being absent in 500 other reference sequences deposited in GenBank (p = 0.0135 for 
association with microcephaly by two-tailed Fisher’s Exact Test). The original ZIKV inoculum as well as placenta 
and fetus from dam 1 retained the original phenylalanine residue at that position.
Figure 3. Immunohistochemical 4G2 antibody labeling against Flavivirus E-protein in the placenta of a ZIKV 
infected marmoset dam. The pregnant adult marmoset (dam 2) was inoculated at days 79 and 83 of gestation 
(human equivalent of 14 weeks). Placental tissue was collected upon expulsion following spontaneous abortion 
occurring 16 days post-infection (DPI). (A) Vero cells replicating ZIKV were fixed at 6 DPI as positive control 
(4G2) (Ai); to control for non-specific labeling, ZIKV infected Vero cells were probed with only secondary 
antibody (negative) (Aii). (B) 4G2-specific chromogenic signal is apparent with in situ labeling of marmoset 
placental villi in the parenchyma (Bi) but not negative controls (Bii,iv). Areas imaged at 60x high power (B,i-ii) 
are indicated by dashed boxes in B iii and iv (4G2 labeled and negative control, respectively).
www.nature.com/scientificreports/
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Whole blood maternal transcriptome profiling. Whole blood from both the asymptomatic ZIKV-infected 
dams collected at post-infection days 2 (for only 1 of 2 dams), 7, and 30 were collected for transcriptome profiling 
by RNA-seq, and compared to whole blood samples drawn from the same animals prior to ZIKV inoculation. 
Each sample was sequenced in duplicate to increase statistical power. The average sequencing depth was 23.9 M 
reads per sample (±6.7 M reads) (Supplementary Fig. S1), and STAR/Cufflinks detected an average of 55.1% 
(±9.8%) of all Ensembl isoforms in each sample.
We analyzed the RNA-seq data for differentially expressed genes (DEGs) at 2, 7, and 30 days post-infection 
relative to the uninfected baseline. Distinct from our previously published in male marmosets, in which maximal 
differential expression was observed at day 7 post-ZIKV infection22, differential gene expression in pregnant 
marmoset dams peaked by day 2 post-infection, returning to near baseline by day 30 (Supplementary Table S2). 
Canonical pathway analysis showed that the interferon signaling pathway was the top pathway significantly 
up-regulated at both days 2 and 7 post-infection (Supplementary Fig. S2A). Most of the differentially up-regulated 
genes corresponded to the type I interferon pathway, although both type I and type II pathways were predicted to 
be activated (Supplementary Fig. S3). Cytokine profiling assays showed increases in activity of a number of proin-
flammatory cytokines (Supplementary Fig. S2B). After subtracting DEGs found in common with ZIKV-infected 
male marmosets22, we used gene ontology analysis with the PANTHER database34 to evaluate the 29 remaining 
DEGs at day 7 for those that may be playing a role in the fetal loss and neuropathology (Supplementary Table S3). 
Two such candidate genes among the 29 were identified: TRPV6, a member of the TRP membrane family that 
plays a role in maternal-fetal Ca2+ transport, and LYPD6, a regulator of Wnt/β-catenin signaling involved in 
embryogenesis, tissue homeostasis, and regeneration.
Discussion
Rodents, including laboratory mice, are not a natural host of ZIKV infection because their IFN-driven immune 
responses can inhibit ZIKV replication11,26,35. As a result, murine models of ZIKV infection require IFN manip-
ulation and are thus inherently limited in their potential for both translational relevance and mechanisms of 
Figure 4. In situ hybridization + and − single strand RNA (ssRNA) oligonucleotide probes in spontaneously 
aborted marmoset (dam 2) placental tissue. The concomitant labeling of both + and − ssRNA is indicative 
of actively replicating ZIKV. Villous sections were hybridized using amplified probe sets against the +ssRNA 
the −ssRNA genome to localize active viral replication in the placenta. Fixed Vero cells actively replicating 
ZIKV at 6 DPI were used as positive controls (A). Placental tissue sections were highly positive for the presence 
of genomic RNA in villous parenchyma (B,i-ii). Furthermore, ubiquitous detection via ISH of the negative 
replication strand indicated ZIKV as established in the fetal-placental tissue of the chorionic villi (B,iii-iv). A 
probe set against human peptidylprolyl isomerase (PPID) mRNA was used as a negative control (B,v-vi). (C) 
Examination of H&E stained sections of the placental villous revealed no leukocyte infiltration. Dashed boxes 
denote the zoomed area depicted at high power (60X).
www.nature.com/scientificreports/
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congenital pathogenesis11,26,35,36. Here we show that ZIKV inoculation of pregnant marmosets causes a maternal 
asymptomatic infection and seroconversion similar to that seen in humans. This maternal infection is measured 
as prolonged viremia and viruria, and is accompanied by active viral replication in the placenta, with resultant 
fetal infection, a predominant neuropathology of the developing fetal brain and eye, and early demise. Although 
atypical for non-pregnant human cases, persistence of virus in serum and urine (i.e. viremia and viruria) beyond 
14 days and as long as 8 months has been reported in ZIKV-infected pregnant women33,37, and is felt to be due to 
permissive replication in the placenta and/or fetus functioning as a viral reservoir3,29. In both inoculated dams, 
spontaneous abortion was observed 16–18 days post infection, with extensive productive viral infection in the 
placenta and fetal tissues documented by qRT-PCR, immunohistochemistry, and ISH for (+) and (−) ssRNA 
strands. We also visualized direct infection of neural progenitor cells associated with disorganized migration. 
The most straightforward explanation for the measured 50% expected biparietal diameter of the fetuses from 
dam 1 is cranial collapse following intrauterine demise; however, we also cannot rule out this finding as an early 
predictor of microcephaly since it is temporally and spatially accompanied by aberrant migration patterns which 
Figure 5. Maternal ZIKV infection during placentation in the marmoset yields later limited active viral 
replication in the fetal thorax and abdomen, with fetal expulsion 14 DPI. Dam 1 was inoculated at days 
68 and 72 of gestation (human equivalent of 14 weeks). Morphometric analysis of H&E stained sections 
revealed tissue and organ typing, with labeling of ZIKV +ssRNA and −ssRNA localized regions of active 
viral replication. Overall signal was diffuse across many tissues but was not stronger than placenta (Fig. 2). 
(A) Histological sections of the abdomen demonstrate hepatic autolysis (i, arrow) with strong +ssRNA and −
ssRNA ZIKV labeling indicative of active viral replication (ii-iii). (B) Microscopic sections of the superior right 
hypochondriac anterior thorax (rib cartilage, black arrows) just superior to the liver tissue (white arrow) (Bi) 
with scant evidence of active viral replication by - ssRNA labeling the primitive mesenchymal and muscle tissue 
around the rib show signal (B,ii-iii). (C) Sections around the developing cervical vertebrae in the posterior 
thorax (i, arrows) with rare dual ssRNA labeling indicative of scant active ZIKV replication in the muscle and 
immature mesenchymal tissue. Hybridization probe-free serial-sections were used as negative controls. Dashed 
boxes denote the zoomed area depicted.
www.nature.com/scientificreports/
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are hallmarks of secondary microcephaly. In 1 of the 2 inoculations, a spontaneous de novo mutation, F252L, 
shared in common with a ZIKV genome from a human case of microcephaly, was identified. Finally, maternal 
interferon-associated host responses and increased activity of proinflammatory cytokines were demonstrated 
at early as day 2 post-inoculation. Collectively, these findings reveal several intriguing and novel mechanistic 
insights pertaining to the potential roles of placental replication, mutation-driven viral adaptation, and maternal 
responses in ZIKV-mediated fetal pathogenesis.
The first trimester of pregnancy in both humans and marmosets is critical for appropriate development of 
the major organ systems, especially the brain and its associated neuroprogenitor cells. Gestational ages of 79–83 
days (dam 1) and 68–72 days (dam 2) at the time of inoculation correspond to approximately 6.6–8.6 weeks in 
humans (Fig. 2), and is a time of crucial placental development in the marmoset. Indeed, the marmoset spends 
a third of its entire 143-day gestation invested in placentation. When compared to the human, which completes 
organogenesis by day 56 of a 266-day gestation, the marmoset will not complete organogenesis until day 80 
(Fig. 2). Spontaneous abortion rates in the absence of congenital viral infections at this stage are hard to docu-
ment, given the small sizes of the placental and fetal material being expelled; however, the available data indicate 
that two abortions in this gestational age range is an unexpected, spontaneous finding. For 2016–17, the SNPRC 
Figure 6. Maternal ZIKV infection during placentation renders significant latter neurophthalmic viral 
replication. Tissues in the fetus from dam 2 were identified based on morphology using H&E stained sections 
under low (A) and medium power (B,C). (A) Shown is a frontal cross section taken immediately posterior to 
the eye. Visible features are identified in an H&E stained section, including orbital bone, ocular muscles and 
nerves, as well as cortical plate of the frontal brain (i). Areas immediately posterior to the eye, inclusive of the 
ocular muscle and socket, demonstrated active viral replication as measured by dual labeling of both ssRNA 
strands (ii-iii, arrows). (B) A boxed area from the same slide at higher magnification showing nerve. Although 
relatively acellular, the perineurium is constituted of macrophage-like epithelioid myofibroblasts (i, dashed 
line). Perineural cells around a nerve focally showed the highest replication (ii,iii). (C) A boxed area at higher 
magnification showing brain. Cortical plate (CP) neurons are seen to be strongly infected (arrows).
www.nature.com/scientificreports/
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non-infected marmoset colony documented two abortions with placental/fetal material indicating this gesta-
tional age range out of 103 pregnancies (1.9%). The most comprehensive data documenting loss rates at this stage 
of marmoset pregnancy come from hormonal verification of pregnancy and pregnancy loss in a large (n = 596) 
number of marmoset pregnancies in a research colony in Berlin38. The investigators documented a pregnancy 
Figure 7. ZIKV infected dam 1 fetus during latter stages of placentation demonstrates ongoing vertical 
maternal-fetal transmission with active replication in the frontal brain and fetal eye. (A) Low-power H&E 
stained sagittal cross-section provided anatomic orientation for dam 1 fetus. The primitive eye (PE) with retinal 
pigment, eye muscle (EM) and the optic nerve (ON) are identified. Boxed areas indicate the location of ZIKV 
probed in serial sections (B–D). The most highly infected area within the fetal head cross section was found to 
be the mesenchymal cells of the ocular muscle (Bii,iii).
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loss rate during days 80–142 of 4.4%; our finding of 2 of 2 ZIKV-infected pregnancies resulting in spontaneous 
abortion is thus statistically significant (p = 0.011 by Fisher’s Exact Test). In comparison, the overall loss rate in 
experimentally ZIKV-infected macaques at a comparable stage of embryonic development is 38%, as compared to 
expected non-infected loss rates of approximately 4–10% (Dudley et al., under review). In humans, documented 
rates of pregnancy loss due to ZIKV across all 3 stages at time of infection are estimated to be ~3%, with 8% of 
completed pregnancies following infection during the first trimester resulting in ZIKV-associated birth defects4. 
However, due to inherent limitations in the studies of miscarriages, early and mid-gestation ZIKV-induced preg-
nancy loss has been likely underreported and largely limited to case reports and limited retrospective series25,39. 
We speculate that our observation of uniform pregnancy loss in our marmoset model is a highly significant novel 
finding of potential translational significance and worthy of prioritized further human studies and re-analysis of 
existing epidemiologic data40.
Only rodents rendered deficient of type I interferon through experimental manipulations are highly sus-
ceptible to maternal-fetal transmission and resultant congenital disease26,35. It is thus important to note that in 
ZIKV-infected pregnant marmoset dams, maximal RNA-seq differential expression between the infected and 
uninfected state and significant up-regulation of interferon-associated genes in peripheral blood were observed at 
day 2. This early IFN systemic burst in pregnant dams is in contrast to day 9 in a previous study of ZIKV-infected 
male marmosets22. This may reflect the enhanced susceptibility of pregnant versus non-pregnant individuals to 
ZIKV infection, driving a more rapid host response and resulting in higher viral loads as well as persistence in 
body fluids and tissues33,37. In addition, it may provide crucial insight into the role of the placenta as both reser-
voir and conduit. We found early (day 2) increases in the concentrations of several proinflammatory molecules, 
including IFN-γ, which drives the type II interferon pathway. Interestingly, an antiviral response characterized 
by increased interferon and proinflammatory cytokine activity has been previously reported in association with 
ZIKV infection of primary human placental macrophages (Hofbauer) cells and cytotrophoblasts41. Here we 
observed extensive ZIKV infection of the placenta and fetus in the absence of overt inflammation and despite 
induction of a robust host antiviral response. This is consistent with ours and others recently described human 
placental pathogenesis39,42–47.
Among the 31 candidate DEGs at day 7 post-infection, the decreased expression of TRPV6 and LYPD6 rel-
ative to baseline is especially intriguing. TRPV6 is highly expressed in placenta48, and has been shown to be 
critical for maternal-fetal Ca2+ transport and fetal Ca2+ homeostasis in an aromatase knockout pregnant mouse 
model49. In this mouse model, decreased expression of TRPV6 was associated with estrogen deficiency, which 
increases risk of miscarriage50. Like TRPV6, LYP6 is highly expressed in placenta51, and was critical for normal 
neuroectodermal development by way of Wnt/β-catenin signaling in zebrafish embryos52. Further studies are 
needed to determine whether viral suppression of these highly expressed maternal placental genes plays a role 
in the spontaneous abortions and disrupted fetal neurodevelopment seen here in association with first-trimester 
ZIKV infection.
An important point of consideration for applying our current findings to human congenital disease is an 
appreciation of the timeline of embryonic and placental development in marmoset monkeys versus humans. 
Marmosets have a delayed period of embryogenesis relative to humans (Fig. 2), resulting in the marmoset 
undergoing critical stages of neural development in association with a relatively far more mature placenta (both 
structurally and in terms of duration of the placenta as a functioning organ). Our findings further suggest that 
marmosets may be particularly sensitive to fetal Zika infection with respect to fetal loss, perhaps related to the 
initial infection of a relatively mature placenta when considered against their human counterparts (Fig. 2).
Our findings herein summarily show that the marmoset model faithfully recapitulates key characteristics of 
CZS in humans that are not observed in other rodent nor NHP models. Notably, ZIKV-infected rhesus macaques 
exhibited no fetal CNS abnormalities with maternal infection15. Pigtail macaques exhibited neural injury with 
severe hypoplasia and asymmetry within the occipital-parietal lobes9, but did not manifest the diffuse effects on 
neuroprogenitor cells observed in both the marmoset and human cases. In contrast, neuronal disorganization in 
Figure 8. Maternal infection during placentation renders latter fetal cortical brain infection with disorganized 
neuronal migration. (A) Low power sagittal view of the posterior developing cranium and brain of the dam 1 
fetus localizing the cortical plate (CP) and the migrating neurons (MN). (B) Higher power view of the migrating 
layer showing significantly disorganized migrating neurons, (arrows). The boxed area in A localizes the higher 
power field B.
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ZIKV-infected pregnant marmosets was observed during early gestation at the posterior and crown in what will 
later comprise the occipital–parietal lobes (Fig. 8). We speculate that the capacity for the marmoset to better reca-
pitulate human infection is related to ongoing placental development and trophoblast renewal, whereby the virus 
is permissive to replication in both placental trophoblasts42 and placental macrophages (Hofbauer cells)39 without 
evidence of inflammation39,42–47. As is likely the case in humans, the placenta may be viewed as an effective “shut-
tle” to the fetus, functioning first as a reservoir and later as a source of fetal infection of susceptible cell types and 
tissues, including neuroprogenitor cells43. Nevertheless, in fetuses from both dam 1 and dam 2, the virus appears 
to have caused injury to the neocortex documented by histopathological examination and neuronal disorganiza-
tion in the absence of localized inflammation, as also seen in mouse models11 and human cases44.
For both ZIKV-infected marmosets and humans, fetal infection appears to be established in the absence of 
localized fetal and placental inflammation39,42–47. However, there is clear evidence of injury to the fetal neocortex 
as visualized by histopathological examination showing neuronal organization, mimicking findings in mice mod-
els of ZIKV vertical transmission as well as human cases11,44. This notion of the significance of placental mechan-
ics and placental cell infection in the pathogenesis in CZS has been previously brought forward by a number of 
investigators36,41–43,45–47,53. It has long been supposed that shuttling of bloodborne ZIKV to the developing human 
fetus requires establishment of maternal blood in the intervillous space, which occurs approximately at 6–8 weeks 
post-conception (mean of roughly 42 days) (Fig. 2), or 8–10 weeks of pregnancy, corresponding to the late first 
trimester. However, epidemiologic observations reveal that both first and second trimester are highly vulnerable 
windows of CZS susceptibility4,40. It has thus been unclear whether CZS susceptibility in the first trimester may 
relate to leaks in placental architecture or shifting antiviral capacity of the maturing trophoblast36.
Our results here document a definitive role for early infection of a maturing placenta in the response to ZIKV 
infection during the critical period of fetal neurodevelopment (Fig. 2). We observed (1) active and robust ZIKV 
replication in the absence of local inflammation, (2) a maternal host response dominated by interferon type I and 
II-associated genes and proinflammatory cytokines, and (3) evidence of a functional placenta (normal amniotic 
fluid volume) and viable fetus despite viral replication and disruption of neuronal migration in developing brain 
and eye demise. Taken together, these findings suggest that contemporary ZIKV strains are capable of both rep-
licating in the placenta and migrating to the developing fetus despite robust antiviral maternal responses. Our 
findings are consistent with previous work showing that multiple placental cell types, including macrophages, 
cytotrophoblasts, and primary human trophoblasts, are permissive to ZIKV infection39,41–47. Thus, our studies 
in both humans and marmoset reveal that the placenta likely serves both as a conduit for fetal infection and a 
reservoir for ongoing replication41,42.
Contemporary ZIKV strains may have evolved to acquire the capacity for placental replication and fetal neu-
ropathogenesis36,41,42. Notably, viral genome sequencing showed both viruses retained the S139N mutation in the 
pre-membane (prM) protein (associated with increased ZIKV infectivity of neural progenitor cells and more severe 
microcephaly in a mouse model54). Of note, the African strains used in the work of Bayer et al.45, where they failed 
to see robust ZIKV replication in primary human trophoblasts, did not demonstrate the S139N mutation. The virus 
from dam 2 had a further de novo F252L coding mutation shared in only 1 of 6 available microcephalic ZIKV 
genomes in humans33. The serendipitous finding of a F252L coding mutation is unlikely to be coincidental, as the 
mutation was not seen in any of the other 603 ZIKV genomes sequenced to date not associated with microcephaly 
(p = 0.0135). Further investigation of the potential functional significance of the F252L mutation is warranted.
We are enthused by both the potential relevance and significance of our findings employing pregnant mar-
mosets. First, they show that the marmoset faithfully recapitulates all crucial aspects of human CZS and does not 
require the exogenous manipulation of interferons, necessary in murine models11,26,35,36. Given the capacity for 
the marmoset to complete multifetal gestations in 143 days and undergo repeat pregnancy within 10 days, this is 
an efficient model whose reproductive capacity over short time intervals rivals most rodent models. Second, these 
studies underscore crucial mechanistic insights pertaining to the role of the placenta in modulating (or failing to 
modulate) congenital infection and maternal-to-fetal transmission. Understanding the role of placental permis-
siveness in this process is of utmost crucial importance and reinforces the emerging notion of the placenta not as 
a de facto barrier, but as an active conduit for maternal and fetal communication during gestation. Thus, the iden-
tification of drugs not only to treat or prevent ZIKV infection of the fetus but also to prevent placental infection 
and viral transport may be critical to prevent the irreversible neuronal damage associated with CZS. Third and of 
potential crucial clinical importance, our findings demonstrate a high rate of pregnancy loss with maternal ZIKV 
infection and placental and fetal transmission. These observations should prompt reexamination of human epi-
demiologic data and provide additional endpoints in prospective studies as ZIKV continues to emerge in newly 
endemic communities in Texas, Florida, and other at-risk regions of the Americas.
Methods
Marmoset inoculation and sample collection. Animal studies were conducted at the Southwest National 
Primate Research Center (SNPRC), an AAALAC-accredited program. All studies were reviewed and approved by 
the local Institutional Animal Care and Use Committee (IACUC) and Biohazard Committee.
Two pregnant dams (4.2 and 3.8 years of age; 474 and 422 grams body weight) were inoculated intramus-
cularly with 0.25 mL containing with 2.5 × 105 plaque forming units (PFU) of the Brazil ZIKV strain SPH2015 
diluted in saline (GenBank accession number KU321639)55, followed by a second identical inoculation 4 days 
later. The gestational age of the embryos at the time of inoculation was determined by crown-rump length, 
which we have previously demonstrated to provide a reliable gestational age to within +/−3 days56. Embryonic 
growth was tracked by ultrasonography performed on unsedated animals. For dam 1, ultrasound exams took 
place on days 80, 88, and 93, confirming two live embryos with biparietal diameters as expected for those ages. 
Ultrasounds on dam 2 were on days 78 and 82, confirming one live embryo. In each case, the number of embryos 
was consistent from pre-dosing screening through the infection period.
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Following ZIKV infection, pregnant dams were monitored daily for symptoms. Both females gained weight over 
the period from inoculation to abortion (0.4 grams −1.5 grams per day), within or exceeding the published range of 
weight gain for pregnant dams at mid-term (0.39–0.71 grams/day)57. Urine, blood, and saliva were sampled and serially 
monitored for ZIKV RNA by qPCR testing per a pre-established schedule (Fig. 1A). For the 2 female marmosets, blood 
samples to obtain serum were collected via venipuncture on days -5, 2, 7 and 30; voided urine was collected on days 
-5, 2, 7, 9, 10, 14, 21, and 28; saliva was collected on days -5, 2, 7, 14, 21, 28 and 30 by allowing the subjects to chew on a 
sterile cotton swab. Whole blood samples for transcriptome analysis were collected for dam 1 on days 7 and 30 and for 
dam 2 on days -5, 2, 7, and 30 in tubes containing RNA stabilization media (Biomatrica, Inc.). At day 30, both female 
marmosets were euthanized and their necropsy tissues examined for persistent ZIKV infection (Fig. 1A).
Measurement of ZIKV RNA loads by quantitative RT-PCR. The course of infection in inoculated 
marmosets was monitored by determination of ZIKV RNA loads (expressed as RNA copies/mL) in infected body 
fluids (serum, urine, and saliva) and placental and fetal tissues. ZIKV RNA loads were calculated by generation 
of a standard curve, followed by quantitative RT-PCR testing for 45 cycles using published PCR conditions and 
primers targeting the envelope gene (ZIKV-1086/ZIKV-1162)5. By standard curve analysis, the estimated limit of 
detection for the qRT-PCR assay was ~15 RNA copies per mL.
ZIKV serological analysis by antibody neutralization. Plaque-reduction neutralization assay (PRNT) 
on longitudinally collected marmoset sera was performed by the California Department of Public Health, using 
a protocol adapted from that used by the US Centers for Disease Control and Prevention (CDC) for confirma-
tory ZIKV testing in patients. Briefly, 100 plaque forming units (PFU) of ZIKV (Brazilian SPH2015 strain) were 
mixed with equal volumes of serial 2-fold dilutions of inactivated marmoset sera and incubated for 1 hr at 36 °C, 
followed by inoculation and adsorbing to a monolayer culture of Vero cells for 1 hr at 36 °C. After addition of 3 mL 
of 0.6% agar in Eagle’s Minimal Essential Medium (MEM), plates were placed in a 36 °C, 5% CO2 incubator for 
3 days, followed by addition of 3 mL of 1% agar and 0.004% neutral red in Eagle’s MEM and another 1–2 days of 
incubation until plaques were formed. An 80% or more reduction of the number of plaques compared to positive 
control wells inoculated with virus-diluent mixtures was considered neutralization, with serum titers reported as 
the highest dilution exhibiting 80% or more reduction.
Deep sequencing analysis of ZIKV recovered from marmoset organs and body fluids. Nucleic 
acid was extracted from 50 μg of placenta or fetus lysate, 50 μL of body fluid sample (serum, urine, or saliva), or 
100 μL of viral culture inoculum using the automated Qiagen EZ1 instrument (Qiagen, Valencia, CA), followed 
by treatment with Turbo DNase (Thermo-Fisher, Carlsbad, CA). cDNA was obtained by reverse transcription 
using a 1:5 mix of random hexamer and short spiked primers targeting ZIKV genomes (ref). Next-generation 
sequencing (NGS) libraries were constructed using the Nextera XT kit (Illumina, San Diego, CA), followed by 
single-end, 150 base pair (bp) sequencing on an Illumina MiSeq or HiSeq. 2500 instrument. Raw reads were pre-
processed by adapter trimming and removal of low-quality, low-complexity sequences as previously described58. 
Data was scanned for ZIKV reads using an NCBI BLASTn database constructed from all known ZIKV sequences 
as of October 2017, using an E-value significance threshold of 1 × 10−5. Consensus ZIKV genomes were assem-
bled using Geneious (v10.2.2) by mapping preprocessed ZIKV reads to reference genome KU321639.
Fetal and placental histology and high-resolution imaging. A full sagittal section was mounted 
of one dichorionic fetus from dam 1, and frontal and coronal sections of the singleton dam 2 pregnancy were 
formalin-fixed and paraffin-embedded. Sections were H&E stained to assess for localized inflammation, as well 
as to visualize and identify tissues within the fields. Serial sections of all marmoset tissues were further probed 
for ZIKV viral genome using RNAscope ZIKV probes (Advanced Cell Diagnostic, Inc.) for both + (stable) and 
− (active replicating) RNA strands to determine subcellular localization of viral establishment and active rep-
lication. Probing utilized established methodologies39. Briefly, 4 µM sections were deparaffinized and subjected 
to antigen retrieval as per manufacturer’s instructions (RNAscope 2.5 HD Detection Kit, ACD). A previously 
designed probe set of complementary oligos against either strand, covalently bound to adapter sequences was 
then applied39. The ZIKV sequence specific probe sets consisted of 87 probe pairs requiring hybridization of 
adjacent matching genome sites for adapter probe hybridization and amplification. DAB signal was generated 
after a series of amplification probes as per manufacturer’s instructions. Placenta were also stained with 4G2 anti-
body against flavivirus protein E (Millipore) as previously described42. Vero cells (Green monkey kidney epithe-
lial) infected with contemporaneous ZIKV were used as a positive control. Cells were infected with first passage 
ZIKV HN16 (GenBank: KX928077.1) isolated from traveler returning to the USA from Honduras. Following 
6 days of in vitro infection and replication, scraped cells were formalin fixed in a syringe, then paraffin embedded. 
Bright field slides were examined under low and medium power using a Nikon Eclipse 90i microscope (Nikon 
Instruments, Melville, NY, USA). Minor adjustment for contrast and background levels were made using NIS 
Elements Viewer 4.20 (Nikon) and Adobe Photoshop CC.
Multiplex cytokine analysis of plasma. Plasma samples were analyzed for marmoset cytokines and 
chemokines by Luminex using established protocols for New World primates (Giavedoni, LD. Journal of 
Immunological Methods 301, 89–101, 2005). Evaluation of analytes GRO-α (CSCL1), interferon alpha (IFN-α), 
IFN-γ, interleukin-1 beta (IL-1β), IL-22, monocyte chemoattractant protein 1 (MCP-1, CCL2), macrophage 
migration inhibitory factor (MIF), monokine induced by gamma interferon (MIG, CXCL9), macrophage inflam-
matory protein 1-alpha (MIP-1α, CCL3), MIP-1β (CCL4), regulated on activation, normal T cell expressed and 
secreted (RANTES, CCL5), tumor necrosis factor-alpha (TNF-α), soluble CD40 ligand (sCD40L), soluble inter-
cellular adhesion molecule 1 (sICAM-1), and vascular endothelial growth factor A (VEGF-A) were included in 
this assay. Only analytes quantifiable above the limit of detection are presented.
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Transcriptome analysis. Prior to inoculation, whole blood was drawn from the two age-/sex-matched 
healthy pregnant dams in the ZIKV study to use as internal controls in the transcriptome analysis. All marmosets 
studied here were from a single colony, thus increasing genetic similarities and decreasing environmental bias. 
400 uL microliters of blood were drawn directly into RNAgard tubes (Biomatrica) for immediate RNA stabi-
lization of intracellular RNA at time of collection. Total RNA was extracted using the Biomatrica Blood RNA 
Purification Kit (Biomatrica). The Ovation Human Blood RNA-Seq Kit (Nugen, San Carlos, CA) was used to 
generate RNA-seq libraries from 100 ng of input per sample (as measured using the Invitrogen Qubit RNA HS 
Assay Kit) according to the manufacturer’s protocol. Libraries were sequenced in duplicate as 100 bp paired-end 
runs on an Illumina HiSeq 2500 instrument.
Paired-end reads were mapped to the marmoset genome (Callithrix jacchus Ensembl version 3.2.1), using 
STAR 2.559, and gene and transcript normalized counts were calculated by HTSeq version 0.6.060. Differential 
expression of genes was calculated using linear modeling using the Bioconductor EdgeR software package version 
3.12.261, as implemented in the R programming language. Genes were considered to be differentially expressed 
when their fold change was >±2, p-value < 0.05, and adjusted p-value (or false discovery rate, FDR) < 0.1%. 
Pathway and network analyses of the transcriptome data were performed using Ingenuity Pathway Analysis 
(IPA) software (Qiagen). Marmoset transcriptome data has been submitted to the public National Center for 
Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) repository (accession numbers pending).
The Texas Biomedical Research Institute IACUC approved all protocols for animal experiments.
Statistical Tests. All p-values reported in this study are calculated using two-tailed Fisher’s Exact Test.
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